- Home
- SIBN vs PACB Comparison
SIBN vs PACB Comparison
Compare SIBN & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIBN
- PACB
- Stock Information
- Founded
- SIBN 2008
- PACB 2000
- Country
- SIBN United States
- PACB United States
- Employees
- SIBN N/A
- PACB N/A
- Industry
- SIBN Medical/Dental Instruments
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- SIBN Health Care
- PACB Industrials
- Exchange
- SIBN Nasdaq
- PACB Nasdaq
- Market Cap
- SIBN 606.1M
- PACB 672.8M
- IPO Year
- SIBN 2018
- PACB 2010
- Fundamental
- Price
- SIBN $15.78
- PACB $1.77
- Analyst Decision
- SIBN Strong Buy
- PACB Buy
- Analyst Count
- SIBN 5
- PACB 7
- Target Price
- SIBN $24.60
- PACB $1.90
- AVG Volume (30 Days)
- SIBN 364.8K
- PACB 11.8M
- Earning Date
- SIBN 11-10-2025
- PACB 11-05-2025
- Dividend Yield
- SIBN N/A
- PACB N/A
- EPS Growth
- SIBN N/A
- PACB N/A
- EPS
- SIBN N/A
- PACB N/A
- Revenue
- SIBN $185,262,000.00
- PACB $154,584,000.00
- Revenue This Year
- SIBN $19.94
- PACB $6.06
- Revenue Next Year
- SIBN $16.48
- PACB $15.15
- P/E Ratio
- SIBN N/A
- PACB N/A
- Revenue Growth
- SIBN 22.93
- PACB N/A
- 52 Week Low
- SIBN $11.70
- PACB $0.85
- 52 Week High
- SIBN $20.05
- PACB $2.72
- Technical
- Relative Strength Index (RSI)
- SIBN 57.65
- PACB 48.33
- Support Level
- SIBN $14.74
- PACB $1.91
- Resistance Level
- SIBN $15.31
- PACB $2.37
- Average True Range (ATR)
- SIBN 0.61
- PACB 0.18
- MACD
- SIBN 0.03
- PACB -0.04
- Stochastic Oscillator
- SIBN 84.51
- PACB 16.89
About SIBN SI-BONE Inc.
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.